Last Updated: 01/09/2025
Multi-Stage Malaria Vaccine Consortium: field efficacy testing of a malaria vaccine targeting all four stages of the parasite’s life-cycle
Objectives
To develop vaccines for African infants and children at risk of malaria disease and transmission.
A high-efficacy malaria vaccine is urgently required to reduce the unacceptable burden of malaria mortality and morbidity in Africa. In this project we are developing the first multi-stage vaccine designed to target multiple stages of the P. falciparum malaria parasite’s life-cycle, including the sporozoite, liver, blood and mosquito stages. Testinng of each component of the multi-stage malaria vaccine in clinical trials in Africa to ensure the vaccines are safe, stimulate an immune response, and in some of our studies, are effective in preventing malaria.
Apr 2018 — Mar 2025
$16.31M
Burkina Faso
France
India
Kenya
Sierra Leone
Sweden
Tanzania
The Netherlands
United Kingdom
Related Resources
